Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...
The Dietary Guidelines for America are due by the end of the year, but Trump administration statements raise doubts as to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback